Coenzyme Q10 Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases
Добавки коэнзима Q10 для снижения окислительного стресса: клинические аспекты лечения хронических заболеваний
2020-10-23
SCID: 54.1/qgkd2f8m
Discuss with AI
Antioxidant therapyChronic diseasesCoenzyme Q10 supplementationOxidative stressUbiquinol and ubiquinone
Figures from the paper
Abstract (AI)
Apart from its main function in the mitochondria as a key element in electron transport, Coenzyme Q10 (CoQ10) has been described as having multiple functions, such as oxidant action in the generation of signals and the control of membrane structure and phospholipid and cellular redox status. Among these, the most relevant and most frequently studied function is the potent antioxidant capability of its coexistent redox forms. Different clinical trials have investigated the effect of CoQ10 supplementation and its ability to reduce oxidative stress. In this review, we focused on recent advances in CoQ10 supplementation, its role as an antioxidant, and the clinical implications that this entails in the treatment of chronic diseases, in particular cardiovascular diseases, kidney disease, chronic obstructive pulmonary disease, non-alcoholic fatty liver disease, and neurodegenerative diseases. As an antioxidant, CoQ10 has proved to be of potential use as a treatment in diseases in which oxidative stress is a hallmark, and beneficial effects of CoQ10 have been reported in the treatment of chronic diseases. However, it is crucial to reach a consensus on the optimal dose and the use of different formulations, which vary from ubiquinol or ubiquinone Ubisol-Q10 or Qter®, to new analogues such as MitoQ, before we can draw a clear conclusion about its clinical use. In addition, a major effort must be made to demonstrate its beneficial effects in clinical trials, with a view to making the implementation of CoQ10 possible in clinical practice.
Key Findings
1
Clinical adoption remains uncertain because optimal dosing and the comparative use of formulations, including ubiquinol, ubiquinone, Ubisol-Q10, Qter®, and MitoQ, lack consensus.
2
Clinical trials have investigated CoQ10 supplementation for reducing oxidative stress across cardiovascular, kidney, pulmonary, liver, and neurodegenerative diseases.
3
Coenzyme Q10 functions as a potent antioxidant through its coexisting redox forms, in addition to its mitochondrial role in electron transport.
4
Further rigorous clinical trials are needed to establish consistent benefits and support implementation of CoQ10 in routine practice.
5
Reported benefits suggest CoQ10 may be useful for chronic diseases in which oxidative stress is a defining pathological feature.
Research Object
Coenzyme Q10 supplementation in patients with chronic diseases
Research Subject
The antioxidant effects of Coenzyme Q10 supplementation on oxidative stress and its clinical implications for chronic disease treatment
Publication Details
Publication Date
2020-10-23
Journal
Publisher
ISSN
Cited by
207
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest